FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1391 views | HTML 2060 views | ?
Valérie Gouazé-Andersson1, Marie-Julie Ghérardi1, Anthony Lemarié1, Julia Gilhodes2, Vincent Lubrano3, Florent Arnauduc1, Elizabeth Cohen-Jonathan Moyal1,2,* and Christine Toulas1,2,*
1Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1037/Université Toulouse III Paul Sabatier, Cancer Research Center of Toulouse (CRCT), Toulouse, F-31000, France
2Institut Claudius Regaud, IUCT-O, Toulouse, F-31059, France
3CHU PURPAN-Pavillon Baudot, Place du Dr Baylac, Toulouse-Cedex 3, 31024, France
*These authors contributed equally to this work
Valérie Gouazé-Andersson, email: [email protected], [email protected]
Keywords: FGFR1; FOX; glioblastoma; radioresistance; prognosis biomarker
Received: April 28, 2018 Accepted: July 13, 2018 Published: August 03, 2018
Glioblastoma are known to be aggressive and therapy-resistant tumors, due to the presence of glioblastoma stem cells inside this heterogeneous tumor. We investigate here the involvement of FGFR1 in glioblastoma stem-like cells (GSLC) radioresistance mechanisms. We first demonstrated that the survival after irradiation was significantly diminished in FGFR1-silenced (FGFR1-) GSLC compared to control GSLC. The transcriptome analysis of GSLCs FGFR1(-) showed that FOX family members are differentially regulated by FGFR1 inhibition, particularly with an upregulation of FOXN3 and a downregulation of FOXM1. GSLC survival after irradiation was significantly increased after FOXN3 silencing and decreased after FOXM1 inhibition, showing opposite effects of FGFR1/FOX family members on cell response to ionizing radiation. Silencing FGFR1 or FOXM1 downregulated genes involved in mesenchymal transition such as GLI2, TWIST1, and ZEB1 in glioblastoma stem-like cells. It also dramatically reduced GSLC migration. Databases analysis confirmed that the combined expression of FGFR1/FOXM1/MELK/GLI2/ZEB1/TWIST1 is significantly associated with patients overall survival after chemo-radiotherapy treatment. All these results, associated with our previous conduced ones with differentiated cells, clearly established that FGFR1-FOXM1 dependent glioblastoma stem-like cells radioresistance pathway is a central actor of GBM treatment resistance and a key target to inhibit in the aim to increase the sensitivity of GBM to the radiotherapy.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.